Gencove
Sequencing solutions for global health and sustainability
Sequencing solutions for global health and sustainability
Gencove is a biotechnology startup providing sequencing solutions for global health and sustainability. Since its founding in 2015, the company has been offering high-volume, cost-sensitive sequencing software-as-a-service tailored for academic, agriculture, biotech, diagnostic, and pharmaceutical companies. This enables them to access all the genomic information necessary for making life-saving discoveries.
The company, headquartered in the United States, recently secured a $10.00M Series A investment on 26 October 2021. The investors involved in this funding round include Spero Ventures, Techammer, Third Kind Venture Capital, Version One Ventures, and Lewis & Clark AgriFood.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $10.00M | 5 |
|
26 Oct 2021 |
| Venture Round | $1.82M | - | 15 Mar 2021 | |
| Grant | $330.23K | 1 | National Institutes of Health | 26 Apr 2019 |
| Seed Round | $3.00M | 4 |
|
13 Mar 2019 |
| Seed Round | $1.00M | - | 11 Jul 2017 |
No recent news or press coverage available for Gencove .
We care about your data, and we'd love to use cookies make your experience better.
